An improved nonisotopic test to screen a large series of new inhibitor molecules of poly(ADP-ribose) polymerase activity for therapeutic applications

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1169-1172

  Decker, Patrice ^a   Miranda, Everson Alves ^b,c   De Murcia, Gilbert ^b   Muller, Sylviane ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; 3 METHOXYBENZAMIDE; 4 AMINOBENZAMIDE; 8 HYDROXY 2 METHYL 4(3H) QUINAZOLINONE; BENZAMIDE DERIVATIVE; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; OXIDATIVE STRESS; PRIORITY JOURNAL;

APOPTOSIS; AUTOMATION; DNA DAMAGE; DNA REPAIR; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEOPLASM PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 0032901754     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Althaus, F., and Richter, C. ADP-ribosylation of proteins. Enzymology and biological significance. Mol. Biol. Biochem. Biophys., 37: 1-126, 1987.
2. Oei, S. L., Griesenbeck, J., and Schweiger, M. The role of poly(ADP ribosyl)ation. Rev. Physiol. Biochem. Pharmacol., 131: 127-173, 1997.
3. de Murcia, G., and Ménissier-de Murcia, J. Poly(ADP ribose) polymerase: a molecular nick-sensor. Trends Biochem. Sci., 19: 172-176, 1994.
4. Alvarez-Gonzalez, R., and Althaus, F. R. Poly(ADP-ribose) catabolism in mammalian cells exposed to DNA-damaging agents. Mutat. Res., 278: 67-74, 1989.
5. Lin, W., Amé, J. C., Aboul-Ela, N., Jacobson, E. L., and Jacobson. M. K. Isolation and characterization of the cDNA encoding bovine poly-(ADP ribose) glycohydrolase. J. Biol. Chem., 272: 11895-11901, 1997.
6. Ménissier-de Murcia, J., Niedergang, C., Trucco, C., Ricoul, M., Dutrillaux, B., Mark, M., Oliver, F. J., Masson, M., Dierich, A., LeMeur, M., Walztinger, C., Chambon, P., and de Murcia, G. Requirement of poly(ADP ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. USA, 94: 7303-7307, 1997.
7. Trucco, C., Oliver, F. J., de Murcia, G., and Ménissier-de Murcia, J. DNA repair defect in poly(ADP ribose)-deficient cell lines. Nucleic-Acids Res., 26: 2644-2649, 1998.
8. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
9. Schreiber, V., Molinete, M., Boeuf, H., de Murcia, G., and Ménissier-de Murcia, J. The human poly(ADP ribose) polymerase nuclear localization signal is a bipartite element functionally separate from DNA binding and catalytic activity. EMBO J., 11: 3263-3269, 1992.
10. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP ribose) polymerase. Cell, 81: 801-809, 1995.
11. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillencourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T-T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 576: 37-43, 1995.
12. Shah, G. M., Shah, R. G., and Poirier, G. G. Different cleavage pattern for poly(ADP ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem. Biophys. Res. Commun., 229: 838-844, 1996.
13. Ogawa, N., Dang, H., and Talal, N. Apoptosis and autoimmumty. J. Autoimm., 8: 1-19, 1995.
14. Vaishnaw, A. K., McNally, J. D., and Elkon, K. B. Apoptosis in the rheumatic diseases. Arthritis Rheum., 40: 1917-1927, 1997.
15. Shall, S. ADP-ribose in DNA repair, a new component of DNA excision repair. Adv. Radiat. Biol., 11: 1-69, 1984.
16. Schreiber, V., Hunting, D., Trucco, C., Gowans, B., Grunwald, D., de Murcia, G., and Ménissier-de Murcia, J. A dominant-negative mutant of human poly(ADP ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage. Proc. Natl. Acad. Sci. USA, 92: 4753-4757, 1995.
17. Küpper, J. H., Müller, M., Jacobson, M. K., Tatsumi-Miyajima J., Coyle, D. L., Jacobson, E. L., and Bürkle, A. Trans-dominant inhibition of poly(ADP ribosyl)ation sensitizes cells against γ-irradiation and N-methyl-N′-nitro-N-nitrosoguanidine but does not limit DNA replication of a polyomavirus replicon. Mol. Cell. Biol., 15: 3154-3163, 1995.
18. Pero, R., Olsson, A., Sheng, Y., Möller, C., Kjellén, E., Killander, D., and Marmor, M. Progress in identifying clinical relevance of inhibition, stimulation and measurement of poly ADP-ribosylation. Biochimie (Paris), 77: 385-393, 1995.
19. Thiemermann, C., Bowes, J., Myint, F. P., and Vane, J. R. Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA, 94: 679-683, 1997.
20. Eliasson, M., Sampei, K., Mandir, A. S., Hum, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z., Dawson, T. M., Snyder, S., and Dawson, V. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med., 3: 1089-1095, 1997.
21. Endres, M., Wang, Z., Namura, S., Waeber, C., and Moskowitz, M. A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab., 17: 1143-1151, 1997.
22. Kaufmann, W. K., and Paules, R. S. DNA damage and cell cycle checkpoints. FASEB J., 10: 238-247, 1996.
23. Szabo, C. Role of poly(ADP-ribose) synthetase in inflammation. Eur. J. Pharmacol., 350: 1-19, 1998.
24. Griffin, R. J., Curtin, N. J., Newell, D. R., Golding, B. T., Durkacz, B. W., and Calvert, A. H. The role of inhibitors of poly(ADP ribose) polymerase as resistance-modifying agents in cancer therapy. Biochimie (Paris), 77: 408-422, 1995.
25. Kaanders, J. H., Pop, L. A., Marres, H. A., van der Maazen, R. W., van der Kogel, A. J., and van Daal, W. A. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. Radiother. Oncol., 37: 190-198, 1995.
26. Niedergang, C., Okazaki, H., and Mandel, P. Properties of purified calf thymus poly(adenosine diphosphate ribose) polymerase. Comparison of the DNA-independent and the DNA-dependent enzyme. Eur. J. Biochem., 102: 43-57, 1979.
27. Shah, G. M., Poirier, D., Duchaine, C., Brochu, G., Desnoyers, S., Lagueux, J., Verreault, A., Hoflak, J-C., Kirland, J. B., and Poirier, G. G. Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo. Anal. Biochem., 227: 1-13, 1995.
28. Giner, H., Simonin, F., de Murcia, G., and Ménissier-de Murcia, J. Overproduction and large-scale purification of the human poly(ADP ribose) polymerase using a baculovirus expression system. Gene (Amst.), 114: 279-283, 1992.
29. Mazen, A., Ménissier-de Murcia, J., Molinete, M., Simonin, F., Gradwohl, G., Poirier, G. G., and de Murcia, G. Poly(ADP ribose) polymerase, a novel finger protein. Nucleic Acids Res., 17: 4689-4698, 1989.
30. Kawamitsu, H., Hoshino, H., Okada, H., Miwa, M., Momoi, H., and Sugimura, T. Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. Biochemistry, 23: 3771-3777, 1984.
31. Rankin, P. W., Jacobson, E. L., Benjamin, R. C., Moss, J., and Jacobson, M. K. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J. Biol. Chem., 264: 4312-4317, 1989.
32. Banasik, M., Komura, H., Shimoyama, M., and Ueda, K. Specific inhibitors of poly(ADP ribose) synthetase and mono (ADP-ribosyl) transferase. J. Biol. Chem., 267: 1569-1575, 1992.
33. Boulton, S., Pemberton, L. C., Porteous, J. K., Curtin, N. J., Griffin, R. J., Golding, B. T., and Durkacz B. W. Potentiation of temozolomide-induced cytotoxicity, a comparative study of the biological effects of poly(ADP ribose) polymerase inhibitors. Br. J. Cancer, 72: 849-856, 1995.
34. Kanai, Y., Miwa, M., Matsushima, T., and Sugimura, T. Studies on anti-poly(adenosine diphosphate ribose) antibody. Biochem. Biophys. Res. Commun., 59: 300-306, 1974.